CTRad Biomarker support network

About the network

Translational research potentially allows for better outcomes by enabling better patient selection and/or better prediction of outcome, and also by enhancing the scientific-base of the trial. One of CTRad’s objectives is to stimulate and promote the inclusion of high quality translational research through the wide range of expertise available in CTRad’s membership. CTRad Workstream 1 has developed a network for biomarker and translational research advice, to help both scientists and clinicians develop strong biomarker-based translational components of radiotherapy trials.

The CTRad Biomarker Support Network is made up of radiotherapy biomarker experts, drawn from the CTRad membership. They provide a point of contact for enquiries and can give advice about particular markers, techniques or methodologies, or about other topics such as translational trial design or data processing.

Accessing the network

You can contact the experts in the network directly for enquiries and advice, but please copy in Don Jones and the NCRI CTRad team so that activity can be tracked.

► Contact details and tumour specialisations of network experts, 2013 (PDF)

► Email the CTRad Team

Other relevant support from CTRad

CTRad’s RADCAS service provides specialist advice on the whole radiotherapy trial development process.

► CTRad’s RADCAS service (NCRI webpage)